Walgreens Donates Funds to Support the CDC Foundation's Sustainable Healthcenter Implementation PrEP Pilot (SHIPP) Study

Walgreens and the CDC Foundation continue to collaborate and address public health challenges ranging from HIV/AIDS to Zika

Sep 06, 2017, 12:00 ET from CDC Foundation

DEERFIELD, Ill. and ATLANTA, Sept. 6, 2017 /PRNewswire-USNewswire/ -- Following last year's impactful collaboration between Walgreens and the CDC Foundation addressing the Zika outbreak, the two organizations are once again working together to help address another public health challenge—HIV prevention. To help extend the CDC Foundation's important research and demonstration project, Walgreens made a donation today to help fund the CDC Foundation's Sustainable Healthcenter Implementation PrEP Pilot (SHIPP) study. PrEP (Pre-Exposure Prophylaxis) is a medication protocol for people who do not have HIV to help proactively protect against HIV infection.

To help address the spread of HIV/AIDS, the SHIPP study aims to answer important health services implementation questions about the delivery, outcomes, cost and sustainability of PrEP when provided as a clinical prevention service in community settings. For the purpose of best practices which can be sustained, replicated and scaled across communities, PrEP is being administered by providers using procedures representative of real world use.

"We are very grateful to Walgreens for stepping forward during the early days of the Zika response, and more recently, for their contributions to help prevent the spread of HIV and AIDS through support of our SHIPP study," said Judith Monroe, MD, president and CEO of the CDC Foundation. "Integrating PrEP as a prevention strategy has the capability to change the course of the HIV/AIDS epidemic, but first we must better understand how to increase access, uptake and medication adherence."

According to CDC data, when taken consistently, PrEP has been shown to reduce the risk of HIV infection in people who are at high risk by more than 90 percent. Seen to its completion, the SHIPP study will be a significant and much–needed contribution to the evidence base for future decision-making around PrEP delivery in the United States.

"With a decades-long commitment to the HIV community, at Walgreens we recognize the important role that pharmacies play in addressing the nationwide HIV/AIDS epidemic," said Glen Pietrandoni, senior director of patient care and advocacy for Walgreens. "Supporting the CDC Foundation and its SHIPP study is another way, in addition to providing our patients with HIV testing services as well as medication, for us to contribute to the research and advancement in HIV prevention and treatment. We encourage other potential companies and organizations to join in support of this work."

Pietrandoni added, "Collaborations like the two we have embarked on with the CDC Foundation, play a vital role in getting important health messages out to key audiences. After experiencing the positive outcomes that arose from working together on last year's Zika outbreak, we saw tremendous potential in working with them to help address the HIV/AIDS health challenge."

The 2016 Zika outbreak presented urgent and unique challenges for many high-risk areas and groups around the world, including communicating how to prevent Zika transmission. The CDC Foundation activated its emergency response fund in early 2016 to assist the Centers for Disease Control and Prevention (CDC) during the Zika response. Immediately following this activation, Walgreens joined as one of the first partners in the Zika response for the CDC Foundation, including support for communications activities as well as implementing their own in-store efforts to educate pregnant women in high-risk areas about how to protect themselves and their unborn children from Zika. Specifically, in its stores in Puerto Rico, Walgreens dedicated high-traffic space to providing information on CDC-recommended steps to prevent the spread of Zika virus.

To learn more about opportunities to help fund the completion of the SHIPP study, please contact Rachel Ward Jackson, senior advancement officer for the CDC Foundation, at rjackson@cdcfoundation.org

About the CDC Foundation
The CDC Foundation helps the Centers for Disease Control and Prevention (CDC) save and improve lives by unleashing the power of collaboration between CDC, philanthropies, corporations, organizations and individuals to protect the health, safety and security of America and the world. The CDC Foundation is the sole entity authorized by Congress to mobilize philanthropic partners and private-sector resources to support CDC's critical health protection mission. Since 1995, the CDC Foundation has launched nearly 1,000 programs and raised over $700 million. The CDC Foundation manages over 250 CDC-led programs in the United States and in more than 100 countries. For more information, visit www.cdcfoundation.org. Follow the Foundation on Twitter, Facebook, LinkedIn and Instagram.

About Walgreens
Walgreens (www.walgreens.com), one of the nation's largest drugstore chains, is included in the Retail Pharmacy USA Division of Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the first global pharmacy-led, health and wellbeing enterprise. More than 10 million customers interact with Walgreens each day in communities across America, using the most convenient, multichannel access to consumer goods and services and trusted, cost-effective pharmacy, health and wellness services and advice. Walgreens operates 8,175 drugstores with a presence in all 50 states, the District of Columbia, Puerto Rico and the U.S. Virgin Islands, along with its omnichannel business, Walgreens.com. Approximately 400 Walgreens stores offer Healthcare Clinic or other provider retail clinic services.

View original content with multimedia:http://www.prnewswire.com/news-releases/walgreens-donates-funds-to-support-the-cdc-foundations-sustainable-healthcenter-implementation-prep-pilot-shipp-study-300514842.html

SOURCE CDC Foundation



RELATED LINKS

http://www.cdcfoundation.org